Anxiety - Chemically induced
Research News and Information

Saturday, November 21, 2009

Hyperactivity induced by antiphospholipid syndrome serum.

30 Aug 2009 Antiphospholipid syndrome (APS) is a multisystem disorder characterized by arterial and venous thrombosis, pregnancy morbidity, and neuropsychiatric manifestations. Antiphospholipid IgG injected intracerebroventricularly (i.c.v.) cause behavioral ... Read more...

Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students.

30 Jul 2009 BACKGROUND: Caffeine, the only licit psychoactive drug available to minors, may have a harmful impact on students' health and adjustment, yet little is known about its use or effects on students, especially from a developmental perspective. Caffeine ... Read more...

Anxious arousal and anhedonic depression symptoms and the frequency of current marijuana use: testing the mediating role of marijuana-use coping motives among active users.

29 Jun 2009 OBJECTIVE: The present investigation examined anxious arousal and anhedonic depression symptoms in relation to frequency of past-30-day marijuana use, as well as the role of marijuana-use coping motives in terms of mediating this relation. METHOD: ... Read more...

Latest indexed articles for 'Anxiety - Chemically induced'

These are the very latest articles for this heading:

• Hyperactivity induced by antiphospholipid syndrome serum. 30 Aug 2009
• Mountain Dew or mountain don't?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students. 30 Jul 2009
• Anxious arousal and anhedonic depression symptoms and the frequency of current marijuana use: testing the mediating role of marijuana-use coping motives among active users. 29 Jun 2009
• Antidepressant-induced jitteriness/anxiety syndrome: systematic review. 30 May 2009
• Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. 26 May 2009
• Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. 25 May 2009
• Awake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. 18 May 2009
• Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity. 16 May 2009
• Gamma-aminobutyric acid amides of nortriptyline and fluoxetine display improved pain suppressing activity. 12 May 2009
• [Experimental model of anxiety-depression state in rats exposed to inhibitor of dipeptidyl peptidase IV methionyl-2(S)-cyano-pyrrolidine in early postnatal period] 29 Apr 2009
• A novel operant conflict procedure using incrementing shock intensities to assess the anxiolytic and anxiogenic effects of drugs. 29 Apr 2009
• Nicotine anxiogenic and rewarding effects are decreased in mice lacking beta-endorphin. 15 Apr 2009
• Triple-combination pharmacotherapy for medically ill smokers: a randomized trial. 5 Apr 2009
• Behavioral and neurochemical effects of acute putrescine depletion by difluoromethylornithine in rats. 3 Apr 2009
• Escitalopram in clinical practice in Greece: treatment response and tolerability in depressed patients. 30 Mar 2009
• Effects of lactational exposure to benzo[alpha]pyrene (B[alpha]P) on postnatal neurodevelopment, neuronal receptor gene expression and behaviour in mice. 2 Mar 2009
• Antiepileptic drugs and psychopathology of epilepsy: an update. Mar 2009
• Administration of interferon-alpha in mice provokes peripheral and central modulation of immune cells, accompanied by behavioral effects. 10 Feb 2009
• Functional neuroanatomy of CCK-4-induced panic attacks in healthy volunteers. 30 Jan 2009
• Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. 29 Jan 2009

See a longer list of these articles.

Technical information about 'Anxiety'

Definition: Feeling or emotion of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.

Descriptor UI: D001007

Alternative terms: Anxiety; Anxieties; Nervousness;

Related Mesh Headings: Anxiety Disorders; Anti-Anxiety Agents;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; diagnosis; diet therapy; drug therapy; economics; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; rehabilitation; surgery; therapy; urine; ultrasonography; virology;

Tree Number: F01.470.132;

Technical Notes: human & animal; differentiate from ANXIETY DISORDERS, a psychiatric diagnosis